Meeting Overview | On behalf of our meeting chairs, Eva Kimby, MD, PhD, and Michael Keating, MB, BS, we are pleased to invite you to our symposium “Chronic Lymphocytic Leukemia: Identifying Challenges and Evaluating Solutions” during the 15th Congress of the European Hematology Association in Barcelona, Spain, on 10 June 2010.
|
Location | Fira de Barcelona
Barcelona, Spain
Hall G
16.15 – 18.15
|
Faculty | CHAIRPERSONS
Eva Kimby, MD, PhD
Karolinska University Hospital
Stockholm, Sweden
And
Michael Keating, MB, BS
M. D. Anderson Cancer Center
Houston, Texas, United States
FACULTY
Francesc Bosch, MD
Hospital Vall d'Hebron
Barcelona, Spain
John Gribben, MD, DSc, FRCP, FRCPath, FMedSci
Barts and The London School of Medicine
London, United Kingdom
Anders Österborg, MD, PhD
Karolinska University Hospital
Stockholm, Sweden
Stephan Stilgenbauer, MD
University of Ulm
Ulm, Germany
|
 Agenda |
| 16.15 |
|
Welcome & introduction
Eva Kimby, MD, PhD
|
| 16.20 |
|
Clinical opinion poll
|
| 16.25 |
|
What’s lacking in our current management of chronic lymphocytic leukemia (CLL)?
Stephen Stilgenbauer, MD
|
| 16.45 |
|
Clinical opinion poll |
| 16.50 |
|
Next generation of anti-CD20 antibodies
John Gribben, MD, DSc, FRCP, FRCPath, FMedSci
|
| 17.05 |
|
Clinical opinion poll
|
| 17.10 |
|
Refractory CLL: Improving outcomes with novel strategies
Anders Österborg, MD, PhD
|
| 17.35 |
|
Challenging the experts
All Faculty: Francesc Bosch, MD; Michael Keating, MB, BS; Eva Kimby, MD, PhD; John Gribben, MD, DSc, FRCP, FRCPath, FMedSci; Anders Österborg, MD, PhD; Stephen Stilgenbauer, MD
|
| 18.00 |
|
Symposium pearls
Michael Keating, MB, BS
|
|
|
|
|
Support | Support for this activity has been provided by GlaxoSmithKline
 |
|
